Accumulating literature has unveiled that NR2F2-AS1 is an oncogene in some cancers, including prostate carcinoma, non-small cell lung cancer, and colorectal cancer [12–14]. The gene discussed is NR2F2; the disease is non-small cell lung carcinoma.